» Articles » PMID: 23702080

Evaluation of Amotosalem Treated Platelets over 7 days of Storage with an Automated Cytometry Assay Panel

Overview
Specialty Hematology
Date 2013 May 25
PMID 23702080
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Pathogen Inactivation allows to overcome microbial contamination and growth related to storage of platelets concentrates (PC) at room temperature. The aim of our study was to evaluate the platelet storage lesion extending the storage period of pathogen inactivated platelet concentrates over 7 days using an automated cytometry assay panel.

Methods: We analyzed 43 concentrates subjected to pathogen inactivation (CPPI) at 3, 5 and 7 days evaluating: platelet count, mean platelet volume, platelets at low optical density, platelets at high density, GPIIb-IIIa glycoprotein, platelet microparticles, lactate dehydrogenase. The collection bags (Fenwal) and the IBS kit made in PL2410/PL2411 are approved for the conservation of PC up to 7 days. Data analysis was performed with anova test.

Results: All the parameters except small platelets and PMP were statistically different among day 7 vs. 3 and day 7 vs. 5.

Conclusions: Our study showed a progressive modification of pathogen inactivated platelet concentrates observed up to 7 days. The persistence of the secretory pool and the presence of the platelet membrane fibrinogen receptor suggest the persistence of a potential hemostatic efficacy. Clinical studies are necessary to directly correlate this type of analysis to 24 h recovery or survival of transfused platelets in humans.

Citing Articles

Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets.

Schubert P, Johnson L, Marks D, Devine D Front Med (Lausanne). 2018; 5:129.

PMID: 29868586 PMC: 5949320. DOI: 10.3389/fmed.2018.00129.